124 related articles for article (PubMed ID: 38198885)
1. Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder.
Lou Y; Cheng M; Cao Q; Li K; Qin H; Bao M; Zhang Y; Lin S; Zhang Y
J Pharm Biomed Anal; 2024 Mar; 240():115937. PubMed ID: 38198885
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Vibegron and Mirabegron for Overactive Bladder: A Systematic Literature Review and Indirect Treatment Comparison.
Kennelly MJ; Rhodes T; Girman CJ; Thomas E; Shortino D; Mudd PN
Adv Ther; 2021 Nov; 38(11):5452-5464. PubMed ID: 34537953
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States.
Chen JV; Klein TM; Nesheim J; Mudd PN
J Med Econ; 2022; 25(1):1092-1100. PubMed ID: 35993729
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of LC-MS/MS methods for the determination of mirabegron and its metabolites in human plasma and their application to a clinical pharmacokinetic study.
Teijlingen Rv; Meijer J; Takusagawa S; Gelderen Mv; Beld Cv; Usui T
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():102-11. PubMed ID: 22317789
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Mirabegron and Vibegron in Women With Treatment-Naive Overactive Bladder: A Randomized Controlled Study.
Kinjo M; Masuda K; Nakamura Y; Miyakawa J; Tambo M; Fukuhara H
Urology; 2023 May; 175():67-73. PubMed ID: 36822245
[TBL] [Abstract][Full Text] [Related]
7. Vibegron for the treatment of overactive bladder: a comprehensive update.
Gleicher S; Sebesta EM; Reynolds WS; Dmochowski R
Expert Opin Pharmacother; 2022 Sep; 23(13):1479-1484. PubMed ID: 36124780
[TBL] [Abstract][Full Text] [Related]
8. [Determination of sixteen antibiotics and four
Li ZH; Hu XJ; Lu YF; Xie LN; Zhu Y
Se Pu; 2023 May; 41(5):397-408. PubMed ID: 37087605
[TBL] [Abstract][Full Text] [Related]
9. Evaluating vibegron for the treatment of overactive bladder.
Rechberger T; Wróbel A
Expert Opin Pharmacother; 2021 Jan; 22(1):9-17. PubMed ID: 32993398
[TBL] [Abstract][Full Text] [Related]
10. The 1-year continuation rate and discontinuation factors of vibegron and mirabegron: A retrospective comparative study in a rehabilitation hospital in Japan.
Mukai S; Nomi M; Yamada S; Yanagiuchi A; Sengoku A
Low Urin Tract Symptoms; 2021 Oct; 13(4):448-455. PubMed ID: 34032007
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
12. Determination of Mirabegron in rat plasma by UPLC-MS/MS after oral and intravenous administration.
Chen L; Zhang Y
Rev Assoc Med Bras (1992); 2019 Feb; 65(2):141-148. PubMed ID: 30892436
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Lu S; Jiang K; Qin F; Lu X; Li F
J Pharm Biomed Anal; 2009 Jan; 49(1):163-7. PubMed ID: 19046843
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
[TBL] [Abstract][Full Text] [Related]
16. [Simultaneous determination of 40 plant growth regulators, fungicides, insecticides, and antibiotics in bean sprouts by QuEChERS-high performance liquid chromatography-tandem mass spectrometry].
Feng J; Jiang H; Wang J; Jing Z; Zhang F; Tan T; He F; Jiang L; Li H; Chang S; Li T
Se Pu; 2022 Sep; 40(9):843-853. PubMed ID: 36156631
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects.
Gao H; Cheng M; Liu H; Ding L
J Pharm Biomed Anal; 2023 Sep; 233():115498. PubMed ID: 37285657
[TBL] [Abstract][Full Text] [Related]
18. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study.
Posocco B; Buzzo M; Follegot A; Giodini L; Sorio R; Marangon E; Toffoli G
PLoS One; 2018; 13(2):e0193500. PubMed ID: 29474420
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of domperidone in human plasma by ultraperformance liquid chromatography with electrospray ionization tandem mass spectrometry.
Xu DH; Lou HG; Yuan H; Jiang B; Zhou Q; Zhang ZM; Ruan ZR
Biomed Chromatogr; 2008 Apr; 22(4):433-40. PubMed ID: 18059046
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of fourteen compounds of Hedyotis diffusa Willd extract in rats by UHPLC-MS/MS method: Application to pharmacokinetics and tissue distribution study.
Chen X; Zhu P; Liu B; Wei L; Xu Y
J Pharm Biomed Anal; 2018 Sep; 159():490-512. PubMed ID: 30048897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
